Synthetic compounds to specifically activate or inhibit ryanodine receptor calcium ion channels. The aim of the project is develop synthetic compounds that specifically and reversibly activate or inhibit ryanodine receptor calcium release channels, and will thus increase or reduce the force developed by skeletal muscle and the heart. The compounds will be useful in biomedical and veterinary sciences and in the livestock industry. Some of the compounds that are not effective on mammalian ryan ....Synthetic compounds to specifically activate or inhibit ryanodine receptor calcium ion channels. The aim of the project is develop synthetic compounds that specifically and reversibly activate or inhibit ryanodine receptor calcium release channels, and will thus increase or reduce the force developed by skeletal muscle and the heart. The compounds will be useful in biomedical and veterinary sciences and in the livestock industry. Some of the compounds that are not effective on mammalian ryandine receptor isoforms might interact with insect channels and provide a template for a new class of insecticides. The compounds will be based on naturally occurring peptides which specifically and reversibly modulate mammalian calcium channels.Read moreRead less
Nucleotides for bioelectronics. Bioelectronics is a key component of nanobiotechnology, a new field that merges the science of biological molecules (DNA, proteins etc.) with electronics and semiconductor physics. We have recently introduced redox-labelled nucleotides that enable the production of electrochemically-active DNA and RNA for genetic, forensic and nanotechnology applications. This project further develops redox nucleotides for use in electronic devices.
Selective enrichment of proteins using micro-Gradiflow technology and characterisation of proteins using LC-MS/MS. This project describes crucial areas for the technology development of protein enrichment and fractionation. While current techniques are powerful, the usefulness to identify and characterise proteins of low abundance from massively complex samples in the presence of abundant proteins is limited and requires up to mililitre volumes. We intend to develop the micro-Gradiflow technolog ....Selective enrichment of proteins using micro-Gradiflow technology and characterisation of proteins using LC-MS/MS. This project describes crucial areas for the technology development of protein enrichment and fractionation. While current techniques are powerful, the usefulness to identify and characterise proteins of low abundance from massively complex samples in the presence of abundant proteins is limited and requires up to mililitre volumes. We intend to develop the micro-Gradiflow technology in association with Gradipore as a means of protein fractionation using microlitre volumes of sample. This technology will be applicable to all areas of proteomic research and in particular to the study of cell differentiation. The outcome for Australian industry, our competitiveness both industrial and scientific, and the potential for economic advancement is tremendous.Read moreRead less
The development of tuneable materials to allow the three-dimensional printing of cells. New low cost three-dimensional (3D) printers and reagents will be developed during this project to allow cancer biologists to print cells and polymers as more realistic 3D tissue models for biological assays. Such technology will be important for performing basic research into cancers as well as for providing better tools for drug testing.
Process Induced Protein Aggregation. Blood plasma is a valuable source of therapeutic proteins for the biotechnology industry. Commercial scale processes have been developed to separate the proteins from plasma. Current pumping and filtering operations cause instability and aggregation in the products. This research programme will use novel rheofluorescence and microfluidic methods to identify critical flow and solution conditions that induce deleterious protein aggregation. The knowledge develo ....Process Induced Protein Aggregation. Blood plasma is a valuable source of therapeutic proteins for the biotechnology industry. Commercial scale processes have been developed to separate the proteins from plasma. Current pumping and filtering operations cause instability and aggregation in the products. This research programme will use novel rheofluorescence and microfluidic methods to identify critical flow and solution conditions that induce deleterious protein aggregation. The knowledge developed will be used to assess the effects of different unit operations used by CSL Bioplasma in blood processing to improve process efficiency, reduce product loss and improve product quality. Australia's international competitiveness in biotechnology will be advanced.Read moreRead less
Why is the photosynthetic CO2-fixing enzyme, Rubisco, so inefficient? Dissection of the catalytic chemistry by computational simulation and experimental testing. Fixation of CO2 by the enzyme Rubisco during photosynthesis produces organic compounds which feed all life. Despite this critical role, Rubisco catalyses its reaction sluggishly and, worse, discriminates poorly between CO2 and O2, leading to useless products. Our combined expertise equips us to analyse Rubisco's mechanism using quantum- ....Why is the photosynthetic CO2-fixing enzyme, Rubisco, so inefficient? Dissection of the catalytic chemistry by computational simulation and experimental testing. Fixation of CO2 by the enzyme Rubisco during photosynthesis produces organic compounds which feed all life. Despite this critical role, Rubisco catalyses its reaction sluggishly and, worse, discriminates poorly between CO2 and O2, leading to useless products. Our combined expertise equips us to analyse Rubisco's mechanism using quantum-chemical methods and then test predictions experimentally. We will capitalise on our previous successful studies of Rubisco by addressing emergent issues which are the keys to understanding catalytic efficiency and CO2/O2 selectivity: the roles of a carbamylated lysine; the way CO2 addition is rendered irreversible; and the spin inversion inherent in O2 addition.Read moreRead less
New photoinitiators and polymers for tack-free LED cured surface coatings. This project aims to develop surface coatings curable by energy from Light Emitting Diodes (LEDS) by overcoming existing hurdles, while improving workplace health and safety.
The project expects to achieve this by developing a new class of photoinitiator molecules, with enhanced reactivity, via a unique understanding of synthesis, photochemistry and commercial coatings formulation.
Outcomes will be new surface coatings ....New photoinitiators and polymers for tack-free LED cured surface coatings. This project aims to develop surface coatings curable by energy from Light Emitting Diodes (LEDS) by overcoming existing hurdles, while improving workplace health and safety.
The project expects to achieve this by developing a new class of photoinitiator molecules, with enhanced reactivity, via a unique understanding of synthesis, photochemistry and commercial coatings formulation.
Outcomes will be new surface coatings for a wide range of end uses, publication in high ranking journals and commercialisation of the technology.
Benefits of this project will include elimination of mercury and reduction in exposure to solvents in the Australian workplace, and a lower energy requirement to produce high-quality surface coated products.Read moreRead less
Electronic and Optical Properties of Doped Titanium Dioxide. Titanium dioxide, is widely used as a white pigment, owing to its high refractive index, second, only after diamond. Yellowing of rutile pigment particles, observed on prolonged exposure to sunlight, is a serious problem that pigment manufacturers would like to overcome. It is proposed that aluminium-doping of rutile limits this discolouration by altering the electronic structure of the rutile particles. This project seeks to identify ....Electronic and Optical Properties of Doped Titanium Dioxide. Titanium dioxide, is widely used as a white pigment, owing to its high refractive index, second, only after diamond. Yellowing of rutile pigment particles, observed on prolonged exposure to sunlight, is a serious problem that pigment manufacturers would like to overcome. It is proposed that aluminium-doping of rutile limits this discolouration by altering the electronic structure of the rutile particles. This project seeks to identify the specific electronic cause of the yellowing process, the nature of the Al defect,it's effect on the electronic structure of rutile, and the electronic perturbations that may occur when other dopants are used.Read moreRead less
Development and Testing of Novel Contrast Agents for Diagnostic Imaging. Demand for diagnostic imaging in the Australian healthcare system is growing at over 5% per annum. To facilitate imaging, Australia imports radiographic contrast media costing in excess of $50 million every year. Existing iodine-based agents are not ideal for X-ray absorption in current CT scanners and also cause moderate to severe allergic reaction in around 5% of all patients, sometimes with fatal results. New radiograph ....Development and Testing of Novel Contrast Agents for Diagnostic Imaging. Demand for diagnostic imaging in the Australian healthcare system is growing at over 5% per annum. To facilitate imaging, Australia imports radiographic contrast media costing in excess of $50 million every year. Existing iodine-based agents are not ideal for X-ray absorption in current CT scanners and also cause moderate to severe allergic reaction in around 5% of all patients, sometimes with fatal results. New radiographic media, which give enhanced contrast and provide greater patient comfort and safety are essential. Even a small fraction of the international market would generate millions of dollars in income, support growth and expertise in Imaging Technologies, and provide new markets for Australian mining of rare earth and bismuth metals.Read moreRead less
Discovery and development of novel insulin sensitising compounds for the treatment of Type 2 diabetes. Diabetes is one of the major health problems facing Australia today, and current treatments are proving inadequate to combat this disease. We previously discovered a new drug with potential for development for the treatment of diabetes. In this project, we will identify how this drug works to combat diabetes in cell and animal models, and use novel chemistry approaches to modify the drug to imp ....Discovery and development of novel insulin sensitising compounds for the treatment of Type 2 diabetes. Diabetes is one of the major health problems facing Australia today, and current treatments are proving inadequate to combat this disease. We previously discovered a new drug with potential for development for the treatment of diabetes. In this project, we will identify how this drug works to combat diabetes in cell and animal models, and use novel chemistry approaches to modify the drug to improve its properties and reduce potential side-effects. The outcomes of this project will be understanding of a new biological process that contributes to the development of diabetes, and the discovery and characterisation of new chemical compounds that could be developed as drugs to treat diabetes.Read moreRead less